Nucleic acids encoding parathyroid hormone (PTH) derivatives
    4.
    发明授权
    Nucleic acids encoding parathyroid hormone (PTH) derivatives 有权
    编码甲状旁腺激素(PTH)衍生物的核酸

    公开(公告)号:US07371844B2

    公开(公告)日:2008-05-13

    申请号:US11176735

    申请日:2005-07-08

    CPC分类号: C07K14/635 A61K38/00

    摘要: Parathyroid hormone(PTH) polypeptide derivatives are disclosed, as are pharmaceutical compositions containing said polypeptides, and synthetic and recombinant methods for producing said polypeptides. Also disclosed are methods for treating mammalian conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions containing said polypeptides. Also disclosed are methods for screening candidate compounds of the invention for antagonistic or agonistic effects on parathyroid hormone receptor action. Also disclosed are diagnostic and therapeutic methods of said compounds.

    摘要翻译: 公开甲状旁腺激素(PTH)多肽衍生物,含有所述多肽的药物组合物以及用于产生所述多肽的合成和重组方法。 还公开了使用含有所述多肽的治疗有效的药物组合物治疗哺乳动物状况的方法,其特征在于骨量减少。 还公开了用于筛选本发明的候选化合物对甲状旁腺激素受体作用的拮抗作用或激动作用的方法。 还公开了所述化合物的诊断和治疗方法。

    Nucleic acids encoding PTH functional domain conjugate peptides
    8.
    发明授权
    Nucleic acids encoding PTH functional domain conjugate peptides 失效
    编码PTH功能结构域结合肽的核酸

    公开(公告)号:US07244834B2

    公开(公告)日:2007-07-17

    申请号:US11366391

    申请日:2006-03-03

    IPC分类号: C07H21/04 C07K14/635

    CPC分类号: C07K14/635 A61K38/00

    摘要: Novel parathyroid hormone (PTH) peptides and analogs thereof of the PTH(1–34) fragment are disclosed that combine the N-terminal signaling domain (residues 1–9) and the C-terminal binding domain (residues 15–31) via a linker. Nucleic acid molecules and peptides for PTH(1–9)-(Gly)5-PTH(15–31) (PG5) and PTH(1–9)-(Gly)7-PTH(15–31) and a novel PTH receptor are disclosed. Additionally, methods of screening for PTH agonists, pharmaceutical compositions and methods of treatment are disclosed.

    摘要翻译: 公开了PTH(1-34)片段的新型甲状旁腺激素(PTH)肽及其类似物,其通过以下方式组合N末端信号结构域(残基1-9)和C-末端结合结构域(残基15-31) 接头。 用于PTH(1-9) - (Gly)5-PTH(15-31)(PG5)和PTH(1-9) - (Gly)7-PTH(15-31)的核酸分子和肽和新型PTH 受体。 此外,公开了筛选PTH激动剂,药物组合物和治疗方法的方法。

    Nucleic acids encoding modified parathyroid hormone
    9.
    发明授权
    Nucleic acids encoding modified parathyroid hormone 失效
    编码修饰甲状旁腺激素的核酸

    公开(公告)号:US06803213B2

    公开(公告)日:2004-10-12

    申请号:US10157076

    申请日:2002-05-30

    IPC分类号: C12N1500

    CPC分类号: C07K14/635 A61K38/00

    摘要: The present invention is related to a synthetic and/or recombinant biologically active peptide derivatives of PTH(1-28). Some of the peptides of the invention are at least 90% identical to a peptide consisting essentially of the amino acid sequence X01ValSerGluIleGlnLeuMetHisAsnLeuGlyLysHisLeuAsnSerMetX02ArgValGluTrpLeuArgLysLysLeu (SEQ ID NO:1), wherein X01 is Ser, Ala or Gly; and X02 is Glu or Arg.

    摘要翻译: 本发明涉及PTH(1-28)的合成和/或重组生物活性肽衍生物。 一些本发明的肽与基本上由氨基酸序列X01ValSerGluIleGlnLeuMetHisAsnLeuGlyLysHisLeuAsnSerMetX02ArgValGluTrpLeuArgLysLysLeu(SEQ ID NO:1)组成的肽至少90%相同,其中X01是Ser,Ala或Gly; X02是Glu或Arg。

    Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
    10.
    发明授权
    Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) 有权
    甲状旁腺激素(PTH)和甲状旁腺激素相关肽(PTHrP)的生物活性肽和肽衍生物

    公开(公告)号:US06495662B1

    公开(公告)日:2002-12-17

    申请号:US09421379

    申请日:1999-10-20

    IPC分类号: C07K500

    CPC分类号: C07K7/08 A61K38/00 C07K14/635

    摘要: Novel parathyroid hormone peptide (PTH) and parathyroid hormone related peptide (PTHrP) or derivatives thereof which are biologically active are disclosed, as are pharmaceutical compositions containing said peptides, and synthetic and recombinant methods for producing said peptides. Also disclosed are methods for treating mammalian conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions containing said peptides. Also disclosed are methods for screening candidate compounds of the invention for antagonistic or agonistic effects on parathyroid hormone receptor action. Also disclosed are diagnostic and therapeutic methods of said compounds.

    摘要翻译: 公开了具有生物活性的新型甲状旁腺激素肽(PTH)和甲状旁腺激素相关肽(PTHrP)或其衍生物,以及含有所述肽的药物组合物以及用于产生所述肽的合成和重组方法。 还公开了使用含有所述肽的治疗有效的药物组合物治疗哺乳动物状况的方法,其特征在于骨量减少。 还公开了用于筛选本发明的候选化合物对甲状旁腺激素受体作用的拮抗作用或激动作用的方法。 还公开了所述化合物的诊断和治疗方法。